Delisting Determination, The Nasdaq Stock Market, LLC, July 10, 2023,
Bellicum Pharmaceuticals, Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the common stock of Bellicum Pharmaceuticals, Inc.
(the Company), effective at the opening of the trading session on
July 20, 2023.
Based on review of information provided by the Company, Nasdaq
Staff determined that the Company no longer qualified for listing
on the Exchange pursuant to Listing Rule 5550(b).
The Company was notified of the Staff determination on May 24, 2023.
The Company did not appeal the Staff determination to the Hearings
Panel. The Company securities were suspended on June 2, 2023. The
Staff determination to delist the Company securities became final
on June 2, 2023.